Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2018 May 22;11521:E4900-E4909. doi: 10.1073/pnas.1720584115.
Show Gene links
Show Anatomy links
A selective class of inhibitors for the CLC-Ka chloride ion channel.
Koster AK, Wood CAP, Thomas-Tran R, Chavan TS, Almqvist J, Choi KH, Du Bois J, Maduke M.
???displayArticle.abstract???
CLC proteins are a ubiquitously expressed family of chloride-selective ion channels and transporters. A dearth of pharmacological tools for modulating CLC gating and ion conduction limits investigations aimed at understanding CLC structure/function and physiology. Herein, we describe the design, synthesis, and evaluation of a collection of N-arylated benzimidazole derivatives (BIMs), one of which (BIM1) shows unparalleled (>20-fold) selectivity for CLC-Ka over CLC-Kb, the two most closely related human CLC homologs. Computational docking to a CLC-Ka homology model has identified a BIM1 binding site on the extracellular face of the protein near the chloride permeation pathway in a region previously identified as a binding site for other less selective inhibitors. Results from site-directed mutagenesis experiments are consistent with predictions of this docking model. The residue at position 68 is 1 of only ∼20 extracellular residues that differ between CLC-Ka and CLC-Kb. Mutation of this residue in CLC-Ka and CLC-Kb (N68D and D68N, respectively) reverses the preference of BIM1 for CLC-Ka over CLC-Kb, thus showing the critical role of residue 68 in establishing BIM1 selectivity. Molecular docking studies together with results from structure-activity relationship studies with 19 BIM derivatives give insight into the increased selectivity of BIM1 compared with other inhibitors and identify strategies for further developing this class of compounds.
Abeyrathne,
Biochemical and biophysical approaches to study the structure and function of the chloride channel (ClC) family of proteins.
2016, Pubmed
Abeyrathne,
Biochemical and biophysical approaches to study the structure and function of the chloride channel (ClC) family of proteins.
2016,
Pubmed Accardi,
Structure and gating of CLC channels and exchangers.
2015,
Pubmed Buffington,
Hyponatremia: A Review.
2016,
Pubmed Cabantchik,
Chemical probes for anion transporters of mammalian cell membranes.
1992,
Pubmed Denton,
Novel diuretic targets.
2013,
Pubmed Estévez,
Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
2001,
Pubmed
,
Xenbase Feng,
Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle.
2010,
Pubmed Gradogna,
Alkaline pH block of CLC-K kidney chloride channels mediated by a pore lysine residue.
2013,
Pubmed
,
Xenbase Gradogna,
Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels.
2010,
Pubmed Gradogna,
Dissecting a regulatory calcium-binding site of CLC-K kidney chloride channels.
2012,
Pubmed Harder,
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.
2016,
Pubmed Hooft,
Errors in protein structures.
1996,
Pubmed Imbrici,
ClC-1 chloride channels: state-of-the-art research and future challenges.
2015,
Pubmed Jaroszewski,
Improving the quality of twilight-zone alignments.
2000,
Pubmed Jentsch,
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
2008,
Pubmed Jentsch,
Discovery of CLC transport proteins: cloning, structure, function and pathophysiology.
2015,
Pubmed Liantonio,
Activation and inhibition of kidney CLC-K chloride channels by fenamates.
2006,
Pubmed
,
Xenbase Liantonio,
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.
2016,
Pubmed Liantonio,
Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.
2008,
Pubmed
,
Xenbase Lorenz,
Heteromultimeric CLC chloride channels with novel properties.
1996,
Pubmed
,
Xenbase Maduke,
A decade of CLC chloride channels: structure, mechanism, and many unsettled questions.
2000,
Pubmed Markovic,
The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.
2007,
Pubmed Martinez,
A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.
2008,
Pubmed
,
Xenbase Matsumura,
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.
1999,
Pubmed Matulef,
Discovery of potent CLC chloride channel inhibitors.
2008,
Pubmed McGreal,
Current Challenges in the Evaluation and Management of Hyponatremia.
2016,
Pubmed Miller,
In the beginning: a personal reminiscence on the origin and legacy of ClC-0, the 'Torpedo Cl(-) channel'.
2015,
Pubmed Miller,
ClC chloride channels viewed through a transporter lens.
2006,
Pubmed Miller,
Dimeric structure of single chloride channels from Torpedo electroplax.
1984,
Pubmed Morris,
Stereochemical quality of protein structure coordinates.
1992,
Pubmed Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed Pace,
Protein ionizable groups: pK values and their contribution to protein stability and solubility.
2009,
Pubmed Park,
Structure of a CLC chloride ion channel by cryo-electron microscopy.
2017,
Pubmed Picollo,
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.
2004,
Pubmed Poroca,
ClC Channels and Transporters: Structure, Physiological Functions, and Implications in Human Chloride Channelopathies.
2017,
Pubmed Romero,
The SLC4 family of bicarbonate (HCO₃⁻) transporters.
2013,
Pubmed Rychkov,
Permeation and block of the skeletal muscle chloride channel, ClC-1, by foreign anions.
1998,
Pubmed
,
Xenbase Salhany,
Allosteric effects in stilbenedisulfonate binding to band 3 protein (AE1).
1996,
Pubmed Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed Sambrook,
Purification of nucleic acids by extraction with phenol:chloroform.
2006,
Pubmed Sepela,
Taming unruly chloride channel inhibitors with rational design.
2018,
Pubmed Simon,
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.
1997,
Pubmed Stauber,
Cell biology and physiology of CLC chloride channels and transporters.
2012,
Pubmed Stölting,
CLC channel function and dysfunction in health and disease.
2014,
Pubmed Suh,
Intracellular chloride channels: critical mediators of cell viability and potential targets for cancer therapy.
2005,
Pubmed Thompson,
Isolation and characterization of a high affinity peptide inhibitor of ClC-2 chloride channels.
2009,
Pubmed
,
Xenbase Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed Uchida,
Physiological role of CLC-K1 chloride channel in the kidney.
2000,
Pubmed Venkatachalan,
Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus.
2007,
Pubmed
,
Xenbase Verkman,
Chloride channels as drug targets.
2009,
Pubmed Wallner,
Can correct protein models be identified?
2003,
Pubmed Zaika,
New perspective of ClC-Kb/2 Cl- channel physiology in the distal renal tubule.
2016,
Pubmed Zifarelli,
CLC chloride channels and transporters: a biophysical and physiological perspective.
2007,
Pubmed
